State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness

Journal of Public Health Policy

Volumn 36, Issue 2, 2015, Pages 212-230

  Bramson, Heidi ^a   Des Jarlais, Don C ^a   Arasteh, Kamyar ^a   Nugent, Ann ^a   Guardino, Vivian ^a   Feelemyer, Jonathan ^a   Hodel, Derek ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b AmfAR   (United States)

Author keywords

drugs; HIV; laws; pharmacy sales; PWID; syringe exchange

Indexed keywords

ACQUIRED IMMUNODEFICIENCY SYNDROME; GOVERNMENT; HIV INFECTIONS; HUMAN; LEGISLATION AND JURISPRUDENCE; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV INFECTIONS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; STATE GOVERNMENT; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 84928490472     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2014.54     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. (2001) First report of AIDS. MMWR Morbidity and Mortality Weekly Report 50(21): 429.
2. Gallo, R.C. and Montagnier, L. (2003) The discovery of HIV as the cause of AIDS. New England Journal of Medicine 349(24): 2283-2285.
3. Normand, J., Vlahov, D. and Moses, L.E. (1995) Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington DC: National Academies Press.
4. van Ameijden, E.J., van den Hoek, A.R. and Coutinho, R.A. (1994) Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. American Journal of Public Health 84(2): 275-281.
5. Stimson, G.V. (1995) AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic. Social Science & Medicine 41(5): 699-716.
6. Wodak, A. (1993) Preventing the spread of HIVamong Australian injecting drug users. Forensic Science International 62(1-2): 83-87.
7. Abdul-Quader, A. et al (2013) Effectiveness of structural-level needle/syringe programs to reduce HCVand HIV infection among people who inject drugs: A systematic review. AIDS and Behavior 17(9): 2878-2892.
8. Wodak, A. and Cooney, A. (2006) Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use and Misuse 41(6-7): 777-813.
9. NIDA. (1990) Drugs and violence: Causes, correlates, and consequences. NIDA Research Monograph 103: 1-275.
10. Coyle, M. (2003) Race and class penalties in crack cocaine sentencing: Sentencing project. Paper presented at the annual meeting of the American Sociological Association, 16 August, Atlanta, GA, Atlanta Hilton Hotel, December.
11. Anderson, W. (1991) The New York needle trial: The politics of public health in the age of AIDS. American Journal of Public Health 81(11): 1506-1517.
12. Gostin, L. (1998) The legal environment impeding access to sterile syringes and needles: The conflict between law enforcement and public health. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 18(1): S60-S70.
13. Bluthenthal, R.N., Kral, A.H., Lorvick, J. and Watters, J.K. (1997) Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco. Medical Anthropology 18(1): 61-83.
14. ONDCP. (1992) Needle Exchange Programs: Are They Effective? Executive Office of the President,Washington DC: Office of National Drug Control Policy July, Report No. 7.
15. Gibson, D.R., Flynn, N.M. and Perales, D. (2001) Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15(11): 1329-1341.
16. Bastos, F.I. and Strathdee, S.A. (2000) Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science & Medicine 51(12): 1771-1782.
17. Hellinger, F.J. (1993) The lifetime cost of treating a person with HIV. JAMA 270(4): 474-478.
18. Tempalski, B., Lieb, S., Cleland, C.M., Cooper, H., Brady, J.E. and Friedman, S.R. (2009) HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. Journal of Urban Health 86(1): 132-154.
19. Centers for Disease Control and Prevention
20. Mathers, B. et al (2008) Global epidemiology of injecting drug use and HIVamong people who inject drugs: A systematic review. Lancet 372(9651): 1733-1745.
21. Rothman, K.J. and Greenland, S. (eds.) (1998) Precision and Validity in Epidemiologic Studies. In: Modern Epidemiology. 2nd edn. Philadelphia: Lippincott-Raven, pp. 115-134.
22. Brady, J., Friedman, S., Cooper, H., Flom, P., Tempalski, B. and Gostnell, K. (2008) Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992-2002. Journal of Urban Health 85(3): 323-351.
23. Des Jarlais, D.C. et al (2005) HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health 95(8): 1439-1444.
24. WHO, UNAIDS. WHO, UNODC. (2012) UNAIDS Technical Guide For Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users. Geneva, Switzerland: WHO.
25. Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C. and Hickman, M. (2010) Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed. Lancet 376(9737): 285-301.
26. Des Jarlais, D. et al (2014) Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York city. AIDS and Behavior 18(3): 443-451.
27. Sullivan, S.G. and Wu, Z. (2007) Rapid scale up of harm reduction in China. International Journal of Drug Policy 18(2): 118-128.
28. UNAIDS, World Bank. (2010) Evaluation of the Epidemiological Impact of Harm Reduction Programs on HIV in Vietnam. Washington DC: World Bank.
29. Hathaway, A.D. and Tousaw, K.I. (2008) Harm reduction headway and continuing resistance: Insights from safe injection in the city of Vancouver. International Journal of Drug Policy 19(1): 11-16.
30. Dano, E., An-Tac, I., Belimac, G. and Zhao, P. (2014) Policy breakthrough in needle and syringe program (NSP) for people who inject drugs (PWID) in Cebu city, Philippines. 20th international AIDS Conference, Melbourne Australia. Frado 102.
31. Jolley, E. et al (2012) HIV among people who inject drugs in central and Eastern Europe and central Asia: A systematic review with implications for policy. BMJ Open 2(5): 1-20.
32. Sharma, M., Oppenheimer, E., Saidel, T., Loo, V. and Garg, R. (2009) A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia region. AIDS 23(11): 1405-1413.
33. Krisberg, K. (2010) Funding ban repeal a step forward for needle exchange: Support could bolster HIV prevention. The Nation's Health 40(2): 1-13.